Imatinib mesylate (Gleevec) in the treatment of 2 patients with Philadelphia-positive ALL relapsing after allogeneic stem cell transplantation

Int J Hematol. 2002 May;75(4):440-2. doi: 10.1007/BF02982139.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Benzamides
  • Female
  • Humans
  • Imatinib Mesylate
  • Male
  • Piperazines / administration & dosage*
  • Piperazines / standards
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy
  • Pyrimidines / administration & dosage*
  • Pyrimidines / standards
  • Salvage Therapy
  • Stem Cell Transplantation
  • Transplantation, Homologous
  • Treatment Outcome

Substances

  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate